Insulin aspart biosimilar(Amphastar)
门冬胰岛素生物类似药（Amphastar）
Report date: 2022/09/15 14:45:16
Base Information
Drug NameInsulin aspart biosimilar(Amphastar)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAmphastar Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesAmphastar Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A